NEW YORK ( TheStreet) -- CHANGE IN RATINGS
Berry Petroleum (BRY) downgraded to hold at TheStreet Ratings.
Cirrus Logic (CRUS) upgraded at Oppenheimer to Outperform from Perform, Oppenheimer said. $28 price target. Remains a top back-door play on the growth of Apple.Deckers (DECK) downgraded at Credit Suisse from Outperform to Neutral, Credit Suisse said. Retail comps are decelerating. $91 price target. Eagle Rock Energy Partners (EROC) downgraded to hold at TheStreet Ratings. Sourcefire (FIRE) downgraded at UBS to Neutral from Buy, UBS said. $46 price target. Valuation call. Forest Oil (FST) downgraded at Canaccord from Buy to Hold, Canaccord said. $14 price target. Company is facing higher costs. Graftech (GTI) downgraded at Keybanc from Buy to Hold, Keybanc said. Company faces multiple growth headwinds. World Fuel (INT) downgraded at Evercore from Overweight to Equal-weight, Evercore Partners said. $47 price target. Valuation call, based on lower expected gross profits. Knight Capital (KCG) rated new Buy at Stifel Nicolaus. $16 price target. Company is seeing a better competitive environment. Nabors (NBR) upgraded at Argus from Hold to Buy, Argus Research said. $30 price target. New CEO should be more effective at allocating capital. NII (NIHD)downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. $22 price target. 2012 will likely be a transition year for the company. NII downgraded at BofA/Merrill from Buy to Neutral, Bank of America/Merrill Lynch said. $22 price target. Delayed 3G launch and higher costs will hurt near-term results. Nike (NKE) rated new Equal-weight at Morgan Stanley. Stock is currently valued at a five-year high. PG&E (PCG) added to TPL at Citigroup. $47 price target. Overly punished regarding San Bruno disaster. Target (TGT - Get Report) upgraded at Jefferies to Buy from Hold, Jefferies said. $63 price target. Sales are rebounding andthe EPS revision cycle is bottoming. Under Armour (UA) upgraded at Morgan Stanley from Equal-weight to Overweight, Morgan Stanley said. $106 price target. Company has good sales momentum and potential operating leverage. Wipro (WIT) rated new Perform at Oppenheimer. Could lag peers in topline growth. Wright Medical (WMGI) downgraded at BMO to Market Perform, BMO Capital said. $15 price target. Company cut guidance and faces several quarters of transition.